Cleared Traditional

K843908 - ABBOTT TDT EIA

K843908 is an FDA 510(k) clearance for ABBOTT TDT EIA, manufactured by Abbott Laboratories. The device is a Class 2 Chemistry device with product code CIG cleared through the Traditional 510(k) pathway after a 182-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 1985
Decision
182d
Days
Class 2
Risk

K843908 is an FDA 510(k) clearance for the ABBOTT TDT EIA. Classified as Diazo Colorimetry, Bilirubin (product code CIG), Class II - Special Controls.

Submitted by Abbott Laboratories (Abbott Park, US). The FDA issued a Cleared decision on April 3, 1985 after a review of 182 days - an extended review cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1110 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Abbott Laboratories devices

FDA 510(k) Submission Details - K843908

510(k) Number K843908 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 03, 1984
Decision Date April 03, 1985
Days to Decision 182 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
94d slower than avg
Panel avg: 88d · This submission: 182d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CIG Device Classification - Class 2, Special Controls

Product Code CIG Diazo Colorimetry, Bilirubin
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1110
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - CIG Diazo Colorimetry, Bilirubin

All 185
Devices cleared under the same product code (CIG) and FDA review panel - the closest regulatory comparables to K843908.
DIRECT BILIRUBIN
K860257 · Pointe Scientific, Inc., · Feb 1986
IN-VITRO TEST DETERMINATION TOTAL BILIRUBIN
K854180 · Clinical Data, Inc. · Nov 1985
T-BIL REAGENT, D-BIL REAGENT, SODIUM NITRITE & SUL
K852008 · Alpkem Corp. · May 1985
DATA CHEM AUTO-BILIRUBIN/DIRECT PROCEDURE
K850901 · Data Medical Associates, Inc. · Apr 1985
SYSTEMATE T-BILI 67212
K843328 · Em Diagnostic Systems, Inc. · Sep 1984
SYSTEMATE D-BILI 67213
K843329 · Em Diagnostic Systems, Inc. · Sep 1984